Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,847 | -55,851 | -37,543 | -62,025 | -57,776 |
| Depreciation Amortization | -898 | -1,421 | 248 | 212 | 264 |
| Accounts payable and accrued liabilities | -22 | -1,158 | 1,204 | -886 | 638 |
| Other Working Capital | -4,911 | 5,913 | 861 | -3,444 | 7,439 |
| Other Operating Activity | 6,332 | 9,308 | 4,903 | 9,506 | 6,879 |
| Operating Cash Flow | $-33,346 | $-43,209 | $-30,326 | $-56,637 | $-42,556 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 47,736 | -44,916 | 30,000 | -29,938 | N/A |
| PPE Investments | N/A | N/A | N/A | -16 | -8 |
| Investing Cash Flow | $47,736 | $-44,916 | $30,000 | $-29,955 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,124 | 388 | 305 | 1,220 | 194,496 |
| Other Financing Activity | 0 | -560 | -1,575 | 0 | 0 |
| Financing Cash Flow | $1,124 | $-171 | $-1,270 | $1,220 | $194,496 |
| Beginning Cash Position | 54,527 | 142,823 | 144,419 | 229,791 | 77,858 |
| End Cash Position | 70,041 | 54,527 | 142,823 | 144,419 | 229,791 |
| Net Cash Flow | $15,514 | $-88,296 | $-1,596 | $-85,372 | $151,933 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,346 | -43,209 | -30,326 | -56,637 | -42,556 |
| Capital Expenditure | N/A | N/A | N/A | -16 | -8 |
| Free Cash Flow | -33,346 | -43,209 | -30,326 | -56,654 | -42,564 |